Novartis
NVS
$97.86
Share price
0.08%
Change (1 day)
7.61%
Change (1 year)
Categories
Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.
EPS for Novartis (NVS)
EPS in 2023 (TTM): $3.28
According to Novartis's latest financial reports the company's current EPS (TTM) is $3.28. In 2022 the company made an earnings per share (EPS) of $3.19 a decrease over its 2021 EPS that were of $10.72.
EPS history for Novartis from 2012 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $3.28 | 2.82% |
| 2022 | $3.19 | -70.24% |
| 2021 | $10.72 | 201.97% |
| 2020 | $3.55 | -30.53% |
| 2019 | $5.11 | |
| 2017 | $3.28 | 16.31% |
| 2016 | $2.82 | -61.84% |
| 2015 | $7.39 | 75.53% |
| 2014 | $4.21 | 12.27% |
| 2013 | $3.75 | -2.6% |
| 2012 | $3.85 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $4.84 | 47.60% | 🇺🇸 USA |
 Pfizer PFE | $5.18 | 57.93% | 🇺🇸 USA |
 Abbott Laboratories ABT | $3.66 | 11.44% | 🇺🇸 USA |
 Sanofi SNY | $2.85 | -13.26% | 🇫🇷 France |
 Merck MRK | $5.73 | 74.70% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $3.46 | 5.49% | 🇺🇸 USA |
 AstraZeneca AZN | $1.52 | -53.81% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $8.03 | 144.89% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | -$2.12 | -164.63% | 🇮🇱 Israel |